Parkersburg, WVNCT07784855Now EnrollingIRB Ready

Squamous Cell Carcinoma of Hypopharynx Clinical Trial in Parkersburg, WV

Access cutting-edge squamous cell carcinoma of hypopharynx treatment through this clinical trial at a research site in Parkersburg. Study-provided care at no cost to qualified participants.

Sponsored by West Virginia University

Quick Self-Assessment

See if you qualify for this Parkersburg location

Preparing your pre-screening questions…

Expert Care in Parkersburg

Access squamous cell carcinoma of hypopharynx specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related squamous cell carcinoma of hypopharynx treatment provided free

Apply for This Parkersburg Location

Check if you qualify for this squamous cell carcinoma of hypopharynx clinical trial in Parkersburg, WV

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Parkersburg

    Convenient for WV residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Parkersburg site if eligible
  4. 4Begin participation

About This Squamous Cell Carcinoma of Hypopharynx Study in Parkersburg

Patients undergoing concurrent chemoradiotherapy (CCRT) for head and neck squamous cell carcinoma frequently experience treatment-related toxicities including mucositis, dysphagia, acute kidney injury, pain, constipation, dermatitis, xerostomia, and trismus. Many of these toxicities may be exacerbated by dehydration and are commonly managed with clinician-directed intravenous (IV) hydration. This study will evaluate whether scheduled IV hydration reduces the incidence and severity of treatment-related toxicities compared with clinician assessment-based hydration. Participants will be randomized 1:1 to scheduled IV hydration or clinician assessment-based IV hydration beginning in Week 3 of concurrent chemoradiotherapy and continuing through one week following completion of chemoradiotherapy.

Sponsor: West Virginia University

Who Can Participate

Inclusion Criteria

Non-nasopharyngeal squamous cell carcinoma of oral cavity, oropharynx, hypopharynx, larynx primary
Planned for concurrent chemoradiotherapy (CCRT) with standard-of-care cisplatin-based regimen (IV cisplatin 100mg/m2 once every three weeks for up to three doses or IV cisplatin 40mg/m2 weekly) with concurrent radiotherapy (treatment duration approximately 6-7 weeks, per institutional standards).
The use of immunotherapy in combination with CCRT is permitted and does not affect eligibility or group assignment.

Exclusion Criteria

Nasopharyngeal squamous cell carcinomas, nasal cavity and paranasal sinus squamous cell carcinomas.
History of congestive heart failure.
Dependency on enteral nutrition and hydration prior to enrollment.
Use of diuretics that cannot be safely held during study treatment (participants who are able to temporarily discontinue diuretics during treatment are eligible).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Parkersburg?

Yes, this clinical trial (NCT07784855) has an active research site in Parkersburg, WV that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Squamous Cell Carcinoma of Hypopharynx Treatment Options in Parkersburg, WV

If you're searching for squamous cell carcinoma of hypopharynx treatment options in Parkersburg, WV, this clinical trial (NCT07784855) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Parkersburg research site is actively enrolling participants for this clinical trial. You'll receive care from experienced squamous cell carcinoma of hypopharynx specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all squamous cell carcinoma of hypopharynx clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Hypertension Trials in Parkersburg, WV

See all pulmonary hypertension clinical trials recruiting in Parkersburg — not just this study.

Browse Pulmonary Hypertension Trials in Parkersburg →

Ready to Join in Parkersburg?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Parkersburg, WV